Jubilant Ingrevia Limited (JUBLINGREA) Fair Value & Analysis
Basic Materials · IN · Market cap ₹114B (≈ $1.2B) · ISIN INE0BY001018
What is Jubilant Ingrevia Limited really worth?
A solid business, but trading 76% above our fair value of ₹387.64.
As of Aug 21, 2026, the fair value of Jubilant Ingrevia Limited is ₹387.64 per share against a price of ₹681.15, so the fair value sits 43% below the price. A model estimate blended from multiple valuation models, recalculated regularly.
Strengths
Risks
Fair value as of: Aug 21, 2026
From 24 valuation models · updated 16 days ago
Share price −8.5% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹484.55). The favourable scenario is already priced in.
- Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹215.10 to ₹484.55) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 21, 2026.
How to read this chart
60‑month range ₹348.01 – ₹847.14 · fair‑value band ₹215.10 – ₹484.55 · the ₹681.15 price screens above the ₹387.64 fair value. Dashed = 300-day average. As of Aug 21, 2026.
Analysis
Jubilant Ingrevia Limited (JUBLINGREA) currently trades at ₹681.15, while our model-based Fair Value estimate is ₹387.64, implying the stock looks roughly 75.7% overvalued today. The Quality Score stands at 56/100 (solid quality), in the Basic Materials sector. Bull case: the DCF Models group reads highest at a median of ₹459.01 per share, and 1 of the 24 models we run sit above the ₹681.15 price. Bear case: the Asset-Based group reads lowest at ₹132.81, and 23 of the 24 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Jubilant Ingrevia Limited generated revenue of ₹46.5B at a net margin of 6.6%. Revenue grew 25.3% year over year. It earns a return on equity of 9.2%. Net debt stands at ₹5.9B. Fundamentals as of Aug 21, 2026
Our scenario range runs from ₹215.10 (bear case) to ₹484.55 (bull case); at ₹681.15, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 14% below its 52-week high and 28% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at −58% fair-value upside, at −43%, JUBLINGREA screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2026 figures, and about 5 months have passed since. In that time the company retained roughly ₹8.27 per share, which is 2.2 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 24 models by family
Widest divergence: DCF Models (₹459.01) versus Asset-Based (₹132.81). Highest evidence: EPV (74).
Notify me when JUBLINGREA reaches fair value
Put JUBLINGREA on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 58
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates.
Full company description
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company provides piperidines, metal complexes, choline salts, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, formaldehyde, bio acetic acid-food grade, acetaldehyde, and ethanol, as well as cyano, acetyl, amino, halo, alkyl, and aldehyde pyridines. In addition, it offers route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Jubilant Ingrevia Limited reported revenue of ₹43.4B in FY2026 versus ₹49.1B in FY2022, a compound −3.0%/yr. Reported net income was ₹2.8B in FY2026, compounding −12.6%/yr from FY2022.
JUBLINGREA screens 76% overvalued. Compare with Linde plc →
Peer Group
Specialty Chemicals · 695 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $485.35 | $222.03 | −54% |
| The Sherwin-Williams Company SHW | $344.86 | $143.38 | −58% |
| Ecolab Inc ECL | $286.75 | $96.18 | −66% |
| Air Products and Chemicals, Inc APD | $308.09 | $122.14 | −60% |
| Givaudan SA GIVN | CHF 3,282 | CHF 1,498 | −54% |
| Wanhua Chemical Group 600309 | ¥77.66 | ¥68.03 | −12% |
| 500820 500820 | ₹2,757 | ₹557.43 | −80% |
| Novozymes A/S NSISB | kr 456.40 | kr 169.99 | −63% |
| Asian Paints Limited ASIANPAINT | ₹2,630 | ₹696.23 | −74% |
| PPG Industries, Inc PPG | $114.22 | $71.31 | −38% |
Compare Jubilant Ingrevia Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Jubilant Ingrevia Limited (JUBLINGREA) overvalued or undervalued?
What is the fair value of JUBLINGREA?
What is the quality score of JUBLINGREA?
What is the price target for Jubilant Ingrevia Limited (JUBLINGREA)?
What is the Jubilant Ingrevia Limited stock forecast for 2026?
What is the revenue of Jubilant Ingrevia Limited (JUBLINGREA)?
What is the net profit margin of JUBLINGREA?
Does Jubilant Ingrevia Limited pay a dividend?
Watch Jubilant Ingrevia Limited in the live analysis
One click puts Jubilant Ingrevia Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.